Outcome measures used in studies of botulinum toxin in childhood cerebral palsy: a systematic review (Q37609837)

21 August 2017

1 reference

title

Outcome measures used in studies of botulinum toxin in childhood cerebral palsy: a systematic review (English)

1 reference

21 August 2017

1 reference

1 reference

Micah W Baird

1 reference

21 August 2017

Jilda Vargus-Adams

series ordinal

1 reference

21 August 2017

publication date

6 October 2009

1 reference

Journal of Child Neurology

21 August 2017

published in

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

721-727

1 reference

Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Outcome measurement of effectiveness of botulinum toxin type A in children with cerebral palsy: an ICIDH-2 approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Kinematic aiming task: measuring functional changes in hand and arm movements after botulinum toxin-A injections in children with spastic hemiplegia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Serial casting vs combined intervention with botulinum toxin A and serial casting in the treatment of spastic equinus in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

The effect of botulinum toxin type-A injection on spasticity, range of motion and gait patterns in children with spastic diplegic cerebral palsy: an Egyptian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Comparison of the efficacies of botulinum toxin A and Johnstone pressure splints against hip adductor spasticity among patients with cerebral palsy: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Botulinum toxin effect on salivary flow rate in children with cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Computerized gait analysis of Botulinum Toxin treatment in children with cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Evaluation of botulinum toxin therapy of spastic equinus in paediatric patients with cerebral palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

The effect of spasticity on cortical somatosensory-evoked potentials: changes of cortical somatosensory-evoked potentials after botulinum toxin type A injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Functional improvement in cerebral palsy patients treated with botulinum toxin A injections - preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

A comparison of goal attainment scaling and the Canadian occupational performance measure for paediatric rehabilitation research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809346846

21 January 2018

Identifiers

DOI

10.1177/0883073809346846

1 reference

21 August 2017

1 reference